Larissa Mulka

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Raltegravir is a well-tolerated alternative third agent used in postexposure prophylaxis (PEP). 2 In a single-centre study reviewing reasons for initiation and tolerability of raltegravir-PEP, we(More)
  • 1